HSP90B2P and Hypoglycemia: These findings demonstrate that the hypoglycemia of Hsp–Cu(II) changed the composition and structure of gut microbiota, enriching SCFA-producing bacteria and promoting the SCFA metabolism, suppressing the production of inflammatory factors and reducing intestinal permeability.